#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0028] For biomolecule recognition the most common methods employ fluorescence or chemiluminescent detection.
1-1	0-1	[	_	_	
1-2	1-5	0028	_	_	
1-3	5-6	]	_	_	
1-4	7-10	For	_	_	
1-5	11-22	biomolecule	_	_	
1-6	23-34	recognition	_	_	
1-7	35-38	the	_	_	
1-8	39-43	most	_	_	
1-9	44-50	common	_	_	
1-10	51-58	methods	_	_	
1-11	59-65	employ	_	_	
1-12	66-78	fluorescence	_	_	
1-13	79-81	or	_	_	
1-14	82-98	chemiluminescent	_	_	
1-15	99-108	detection	_	_	
1-16	108-109	.	_	_	

#Text=In this scheme a recognition element with a label element is bound to a molecule of interest and unbound recognition element is removed by a method of washing (Marquette et al., Biosensors & Bioelectronics 2006, 21, 1424-1433).
2-1	110-112	In	_	_	
2-2	113-117	this	_	_	
2-3	118-124	scheme	_	_	
2-4	125-126	a	_	_	
2-5	127-138	recognition	_	_	
2-6	139-146	element	_	_	
2-7	147-151	with	_	_	
2-8	152-153	a	_	_	
2-9	154-159	label	_	_	
2-10	160-167	element	_	_	
2-11	168-170	is	_	_	
2-12	171-176	bound	_	_	
2-13	177-179	to	_	_	
2-14	180-181	a	_	_	
2-15	182-190	molecule	_	_	
2-16	191-193	of	_	_	
2-17	194-202	interest	_	_	
2-18	203-206	and	_	_	
2-19	207-214	unbound	_	_	
2-20	215-226	recognition	_	_	
2-21	227-234	element	_	_	
2-22	235-237	is	_	_	
2-23	238-245	removed	_	_	
2-24	246-248	by	_	_	
2-25	249-250	a	_	_	
2-26	251-257	method	_	_	
2-27	258-260	of	_	_	
2-28	261-268	washing	_	_	
2-29	269-270	(	_	_	
2-30	270-279	Marquette	_	_	
2-31	280-282	et	_	_	
2-32	283-285	al	_	_	
2-33	285-286	.	_	_	
2-34	286-287	,	_	_	
2-35	288-298	Biosensors	_	_	
2-36	299-300	&	_	_	
2-37	301-315	Bioelectronics	_	_	
2-38	316-320	2006	_	_	
2-39	320-321	,	_	_	
2-40	322-324	21	_	_	
2-41	324-325	,	_	_	
2-42	326-330	1424	_	_	
2-43	330-331	-	_	_	
2-44	331-335	1433	_	_	
2-45	335-336	)	_	_	
2-46	336-337	.	_	_	

#Text=Thus a selective signal is produced only when binding occurs..
3-1	338-342	Thus	_	_	
3-2	343-344	a	_	_	
3-3	345-354	selective	_	_	
3-4	355-361	signal	_	_	
3-5	362-364	is	_	_	
3-6	365-373	produced	_	_	
3-7	374-378	only	_	_	
3-8	379-383	when	_	_	
3-9	384-391	binding	_	_	
3-10	392-398	occurs	_	_	
3-11	398-399	.	_	_	
3-12	399-400	.	_	_	

#Text=In most cases the recognition element is immobilized on a surface.
4-1	401-403	In	_	_	
4-2	404-408	most	_	_	
4-3	409-414	cases	_	_	
4-4	415-418	the	_	_	
4-5	419-430	recognition	_	_	
4-6	431-438	element	_	_	
4-7	439-441	is	_	_	
4-8	442-453	immobilized	_	_	
4-9	454-456	on	_	_	
4-10	457-458	a	_	_	
4-11	459-466	surface	_	_	
4-12	466-467	.	_	_	

#Text=These techniques usually require a complicated optical system with a light source, filter, and detector before a signal of binding is determined.
5-1	468-473	These	_	_	
5-2	474-484	techniques	_	_	
5-3	485-492	usually	_	_	
5-4	493-500	require	_	_	
5-5	501-502	a	_	_	
5-6	503-514	complicated	_	_	
5-7	515-522	optical	_	_	
5-8	523-529	system	_	_	
5-9	530-534	with	_	_	
5-10	535-536	a	_	_	
5-11	537-542	light	_	_	
5-12	543-549	source	_	_	
5-13	549-550	,	_	_	
5-14	551-557	filter	_	_	
5-15	557-558	,	_	_	
5-16	559-562	and	_	_	
5-17	563-571	detector	_	_	
5-18	572-578	before	_	_	
5-19	579-580	a	_	_	
5-20	581-587	signal	_	_	
5-21	588-590	of	_	_	
5-22	591-598	binding	_	_	
5-23	599-601	is	_	_	
5-24	602-612	determined	_	_	
5-25	612-613	.	_	_	

#Text=In most cases a large microscope or microplate reader will be used for this purpose.
6-1	614-616	In	_	_	
6-2	617-621	most	_	_	
6-3	622-627	cases	_	_	
6-4	628-629	a	_	_	
6-5	630-635	large	_	_	
6-6	636-646	microscope	_	_	
6-7	647-649	or	_	_	
6-8	650-660	microplate	_	_	
6-9	661-667	reader	_	_	
6-10	668-672	will	_	_	
6-11	673-675	be	_	_	
6-12	676-680	used	_	_	
6-13	681-684	for	_	_	
6-14	685-689	this	_	_	
6-15	690-697	purpose	_	_	
6-16	697-698	.	_	_	

#Text=A common commercial implementation of this technique is the ELISA (Engvall et al., Journal of Immunology 1972, 109, 129).
7-1	699-700	A	_	_	
7-2	701-707	common	_	_	
7-3	708-718	commercial	_	_	
7-4	719-733	implementation	_	_	
7-5	734-736	of	_	_	
7-6	737-741	this	_	_	
7-7	742-751	technique	_	_	
7-8	752-754	is	_	_	
7-9	755-758	the	_	_	
7-10	759-764	ELISA	_	_	
7-11	765-766	(	_	_	
7-12	766-773	Engvall	_	_	
7-13	774-776	et	_	_	
7-14	777-779	al	_	_	
7-15	779-780	.	_	_	
7-16	780-781	,	_	_	
7-17	782-789	Journal	_	_	
7-18	790-792	of	_	_	
7-19	793-803	Immunology	_	_	
7-20	804-808	1972	_	_	
7-21	808-809	,	_	_	
7-22	810-813	109	_	_	
7-23	813-814	,	_	_	
7-24	815-818	129	_	_	
7-25	818-819	)	_	_	
7-26	819-820	.	_	_	

#Text=For portable and cheap diagnostic systems purely electrical detection without optical transduction is desired.
8-1	821-824	For	_	_	
8-2	825-833	portable	_	_	
8-3	834-837	and	_	_	
8-4	838-843	cheap	_	_	
8-5	844-854	diagnostic	_	_	
8-6	855-862	systems	_	_	
8-7	863-869	purely	_	_	
8-8	870-880	electrical	_	_	
8-9	881-890	detection	_	_	
8-10	891-898	without	_	_	
8-11	899-906	optical	_	_	
8-12	907-919	transduction	_	_	
8-13	920-922	is	_	_	
8-14	923-930	desired	_	_	
8-15	930-931	.	_	_	

#Text=A variety of chip-based microfluidic devices have also been developed as diagnostic systems using optical or electrochemical transduction of biomolecule recognition (Yager et al., Nature 2006, 442, 412-418; Warsinke et al., Journal of Analytical Chemistry 2000, 366, 622-634).
9-1	932-933	A	_	_	
9-2	934-941	variety	_	_	
9-3	942-944	of	_	_	
9-4	945-955	chip-based	_	_	
9-5	956-968	microfluidic	_	_	
9-6	969-976	devices	_	_	
9-7	977-981	have	_	_	
9-8	982-986	also	_	_	
9-9	987-991	been	_	_	
9-10	992-1001	developed	_	_	
9-11	1002-1004	as	_	_	
9-12	1005-1015	diagnostic	_	_	
9-13	1016-1023	systems	_	_	
9-14	1024-1029	using	_	_	
9-15	1030-1037	optical	_	_	
9-16	1038-1040	or	_	_	
9-17	1041-1056	electrochemical	_	_	
9-18	1057-1069	transduction	_	_	
9-19	1070-1072	of	_	_	
9-20	1073-1084	biomolecule	_	_	
9-21	1085-1096	recognition	_	_	
9-22	1097-1098	(	_	_	
9-23	1098-1103	Yager	_	_	
9-24	1104-1106	et	_	_	
9-25	1107-1109	al	_	_	
9-26	1109-1110	.	_	_	
9-27	1110-1111	,	_	_	
9-28	1112-1118	Nature	_	_	
9-29	1119-1123	2006	_	_	
9-30	1123-1124	,	_	_	
9-31	1125-1128	442	_	_	
9-32	1128-1129	,	_	_	
9-33	1130-1133	412	_	_	
9-34	1133-1134	-	_	_	
9-35	1134-1137	418	_	_	
9-36	1137-1138	;	_	_	
9-37	1139-1147	Warsinke	_	_	
9-38	1148-1150	et	_	_	
9-39	1151-1153	al	_	_	
9-40	1153-1154	.	_	_	
9-41	1154-1155	,	_	_	
9-42	1156-1163	Journal	_	_	
9-43	1164-1166	of	_	_	
9-44	1167-1177	Analytical	_	_	
9-45	1178-1187	Chemistry	_	_	
9-46	1188-1192	2000	_	_	
9-47	1192-1193	,	_	_	
9-48	1194-1197	366	_	_	
9-49	1197-1198	,	_	_	
9-50	1199-1202	622	_	_	
9-51	1202-1203	-	_	_	
9-52	1203-1206	634	_	_	
9-53	1206-1207	)	_	_	
9-54	1207-1208	.	_	_	

#Text=Here the system integration of optical components or repeatability of electrochemical measurements can be limiting.
#Text=[0029] Microparticles are often used as a stationary site for recognition element immobilization in macroscale (Yingyongnarongkul et al., Combinatorial Chemistry & High Throughput Screening 2003, 6, 577-587) and microfluidic assays (Verpoorte, E., Lab on a Chip 2003, 3, 60n-68n).
10-1	1209-1213	Here	_	_	
10-2	1214-1217	the	_	_	
10-3	1218-1224	system	_	_	
10-4	1225-1236	integration	_	_	
10-5	1237-1239	of	_	_	
10-6	1240-1247	optical	_	_	
10-7	1248-1258	components	_	_	
10-8	1259-1261	or	_	_	
10-9	1262-1275	repeatability	_	_	
10-10	1276-1278	of	_	_	
10-11	1279-1294	electrochemical	_	_	
10-12	1295-1307	measurements	_	_	
10-13	1308-1311	can	_	_	
10-14	1312-1314	be	_	_	
10-15	1315-1323	limiting	_	_	
10-16	1323-1324	.	_	_	
10-17	1325-1326	[	_	_	
10-18	1326-1330	0029	_	_	
10-19	1330-1331	]	_	_	
10-20	1332-1346	Microparticles	_	_	
10-21	1347-1350	are	_	_	
10-22	1351-1356	often	_	_	
10-23	1357-1361	used	_	_	
10-24	1362-1364	as	_	_	
10-25	1365-1366	a	_	_	
10-26	1367-1377	stationary	_	_	
10-27	1378-1382	site	_	_	
10-28	1383-1386	for	_	_	
10-29	1387-1398	recognition	_	_	
10-30	1399-1406	element	_	_	
10-31	1407-1421	immobilization	_	_	
10-32	1422-1424	in	_	_	
10-33	1425-1435	macroscale	_	_	
10-34	1436-1437	(	_	_	
10-35	1437-1454	Yingyongnarongkul	_	_	
10-36	1455-1457	et	_	_	
10-37	1458-1460	al	_	_	
10-38	1460-1461	.	_	_	
10-39	1461-1462	,	_	_	
10-40	1463-1476	Combinatorial	_	_	
10-41	1477-1486	Chemistry	_	_	
10-42	1487-1488	&	_	_	
10-43	1489-1493	High	_	_	
10-44	1494-1504	Throughput	_	_	
10-45	1505-1514	Screening	_	_	
10-46	1515-1519	2003	_	_	
10-47	1519-1520	,	_	_	
10-48	1521-1522	6	_	_	
10-49	1522-1523	,	_	_	
10-50	1524-1527	577	_	_	
10-51	1527-1528	-	_	_	
10-52	1528-1531	587	_	_	
10-53	1531-1532	)	_	_	
10-54	1533-1536	and	_	_	
10-55	1537-1549	microfluidic	_	_	
10-56	1550-1556	assays	_	_	
10-57	1557-1558	(	_	_	
10-58	1558-1567	Verpoorte	_	_	
10-59	1567-1568	,	_	_	
10-60	1569-1570	E	_	_	
10-61	1570-1571	.	_	_	
10-62	1571-1572	,	_	_	
10-63	1573-1576	Lab	_	_	
10-64	1577-1579	on	_	_	
10-65	1580-1581	a	_	_	
10-66	1582-1586	Chip	_	_	
10-67	1587-1591	2003	_	_	
10-68	1591-1592	,	_	_	
10-69	1593-1594	3	_	_	
10-70	1594-1595	,	_	_	
10-71	1596-1599	60n	_	_	
10-72	1599-1600	-	_	_	
10-73	1600-1603	68n	_	_	
10-74	1603-1604	)	_	_	
10-75	1604-1605	.	_	_	

#Text=This is because particles with different elements can be interchanged easily to conduct different assays and the surface area for immobilization is large leading to large optical signals that increase with decreasing particle size.
11-1	1606-1610	This	_	_	
11-2	1611-1613	is	_	_	
11-3	1614-1621	because	_	_	
11-4	1622-1631	particles	_	_	
11-5	1632-1636	with	_	_	
11-6	1637-1646	different	_	_	
11-7	1647-1655	elements	_	_	
11-8	1656-1659	can	_	_	
11-9	1660-1662	be	_	_	
11-10	1663-1675	interchanged	_	_	
11-11	1676-1682	easily	_	_	
11-12	1683-1685	to	_	_	
11-13	1686-1693	conduct	_	_	
11-14	1694-1703	different	_	_	
11-15	1704-1710	assays	_	_	
11-16	1711-1714	and	_	_	
11-17	1715-1718	the	_	_	
11-18	1719-1726	surface	_	_	
11-19	1727-1731	area	_	_	
11-20	1732-1735	for	_	_	
11-21	1736-1750	immobilization	_	_	
11-22	1751-1753	is	_	_	
11-23	1754-1759	large	_	_	
11-24	1760-1767	leading	_	_	
11-25	1768-1770	to	_	_	
11-26	1771-1776	large	_	_	
11-27	1777-1784	optical	_	_	
11-28	1785-1792	signals	_	_	
11-29	1793-1797	that	_	_	
11-30	1798-1806	increase	_	_	
11-31	1807-1811	with	_	_	
11-32	1812-1822	decreasing	_	_	
11-33	1823-1831	particle	_	_	
11-34	1832-1836	size	_	_	
11-35	1836-1837	.	_	_	

#Text=However, microparticle or bead-based bioassays have been limited to fluorescent or colorimetric detection of binding.
#Text=[0030] One of the most typical bead based assay uses a `sandwich assay` (see FIG. 1), where an antibody is attached to the bead surface.
12-1	1838-1845	However	_	_	
12-2	1845-1846	,	_	_	
12-3	1847-1860	microparticle	_	_	
12-4	1861-1863	or	_	_	
12-5	1864-1874	bead-based	_	_	
12-6	1875-1884	bioassays	_	_	
12-7	1885-1889	have	_	_	
12-8	1890-1894	been	_	_	
12-9	1895-1902	limited	_	_	
12-10	1903-1905	to	_	_	
12-11	1906-1917	fluorescent	_	_	
12-12	1918-1920	or	_	_	
12-13	1921-1933	colorimetric	_	_	
12-14	1934-1943	detection	_	_	
12-15	1944-1946	of	_	_	
12-16	1947-1954	binding	_	_	
12-17	1954-1955	.	_	_	
12-18	1956-1957	[	_	_	
12-19	1957-1961	0030	_	_	
12-20	1961-1962	]	_	_	
12-21	1963-1966	One	_	_	
12-22	1967-1969	of	_	_	
12-23	1970-1973	the	_	_	
12-24	1974-1978	most	_	_	
12-25	1979-1986	typical	_	_	
12-26	1987-1991	bead	_	_	
12-27	1992-1997	based	_	_	
12-28	1998-2003	assay	_	_	
12-29	2004-2008	uses	_	_	
12-30	2009-2010	a	_	_	
12-31	2011-2012	`	_	_	
12-32	2012-2020	sandwich	*[1]	15-1[2_1]	
12-33	2021-2026	assay	*[1]	_	
12-34	2026-2027	`	_	_	
12-35	2028-2029	(	_	_	
12-36	2029-2032	see	_	_	
12-37	2033-2036	FIG	_	_	
12-38	2036-2037	.	_	_	
12-39	2038-2039	1	_	_	
12-40	2039-2040	)	_	_	
12-41	2040-2041	,	_	_	
12-42	2042-2047	where	_	_	
12-43	2048-2050	an	_	_	
12-44	2051-2059	antibody	_	_	
12-45	2060-2062	is	_	_	
12-46	2063-2071	attached	_	_	
12-47	2072-2074	to	_	_	
12-48	2075-2078	the	_	_	
12-49	2079-2083	bead	_	_	
12-50	2084-2091	surface	_	_	
12-51	2091-2092	.	_	_	

#Text=An antigen, if it is specific to the antibody, will then bind to the beads.
13-1	2093-2095	An	_	_	
13-2	2096-2103	antigen	_	_	
13-3	2103-2104	,	_	_	
13-4	2105-2107	if	_	_	
13-5	2108-2110	it	_	_	
13-6	2111-2113	is	_	_	
13-7	2114-2122	specific	_	_	
13-8	2123-2125	to	_	_	
13-9	2126-2129	the	_	_	
13-10	2130-2138	antibody	_	_	
13-11	2138-2139	,	_	_	
13-12	2140-2144	will	_	_	
13-13	2145-2149	then	_	_	
13-14	2150-2154	bind	_	_	
13-15	2155-2157	to	_	_	
13-16	2158-2161	the	_	_	
13-17	2162-2167	beads	_	_	
13-18	2167-2168	.	_	_	

#Text=Then, a second antibody that is tagged with a fluorescent molecule is attached to the antigen, forming a `sandwich`.
14-1	2169-2173	Then	_	_	
14-2	2173-2174	,	_	_	
14-3	2175-2176	a	_	_	
14-4	2177-2183	second	_	_	
14-5	2184-2192	antibody	_	_	
14-6	2193-2197	that	_	_	
14-7	2198-2200	is	_	_	
14-8	2201-2207	tagged	_	_	
14-9	2208-2212	with	_	_	
14-10	2213-2214	a	_	_	
14-11	2215-2226	fluorescent	_	_	
14-12	2227-2235	molecule	_	_	
14-13	2236-2238	is	_	_	
14-14	2239-2247	attached	_	_	
14-15	2248-2250	to	_	_	
14-16	2251-2254	the	_	_	
14-17	2255-2262	antigen	_	_	
14-18	2262-2263	,	_	_	
14-19	2264-2271	forming	_	_	
14-20	2272-2273	a	_	_	
14-21	2274-2275	`	_	_	
14-22	2275-2283	sandwich	_	_	
14-23	2283-2284	`	_	_	
14-24	2284-2285	.	_	_	

#Text=This method works well, but a second labeling step is required, and the fluorescence must be monitored with an optical system, a light source, and a photodetector.
#Text=[0031] Another method for detecting biomolecules and their interactions is the bead agglutination assay (Coombs et al., British Journal of Experimental Pathology 1945, 26, 255-266; Reis et al., Transfusion 1993, 33, 639-643).
15-1	2286-2290	This	*[2]	_	
15-2	2291-2297	method	*[2]	_	
15-3	2298-2303	works	_	_	
15-4	2304-2308	well	_	_	
15-5	2308-2309	,	_	_	
15-6	2310-2313	but	_	_	
15-7	2314-2315	a	_	_	
15-8	2316-2322	second	_	_	
15-9	2323-2331	labeling	_	_	
15-10	2332-2336	step	_	_	
15-11	2337-2339	is	_	_	
15-12	2340-2348	required	_	_	
15-13	2348-2349	,	_	_	
15-14	2350-2353	and	_	_	
15-15	2354-2357	the	_	_	
15-16	2358-2370	fluorescence	_	_	
15-17	2371-2375	must	_	_	
15-18	2376-2378	be	_	_	
15-19	2379-2388	monitored	_	_	
15-20	2389-2393	with	_	_	
15-21	2394-2396	an	_	_	
15-22	2397-2404	optical	_	_	
15-23	2405-2411	system	_	_	
15-24	2411-2412	,	_	_	
15-25	2413-2414	a	_	_	
15-26	2415-2420	light	_	_	
15-27	2421-2427	source	_	_	
15-28	2427-2428	,	_	_	
15-29	2429-2432	and	_	_	
15-30	2433-2434	a	_	_	
15-31	2435-2448	photodetector	_	_	
15-32	2448-2449	.	_	_	
15-33	2450-2451	[	_	_	
15-34	2451-2455	0031	_	_	
15-35	2455-2456	]	_	_	
15-36	2457-2464	Another	_	_	
15-37	2465-2471	method	_	_	
15-38	2472-2475	for	_	_	
15-39	2476-2485	detecting	_	_	
15-40	2486-2498	biomolecules	_	_	
15-41	2499-2502	and	_	_	
15-42	2503-2508	their	_	_	
15-43	2509-2521	interactions	_	_	
15-44	2522-2524	is	_	_	
15-45	2525-2528	the	_	_	
15-46	2529-2533	bead	_	_	
15-47	2534-2547	agglutination	_	_	
15-48	2548-2553	assay	_	_	
15-49	2554-2555	(	_	_	
15-50	2555-2561	Coombs	_	_	
15-51	2562-2564	et	_	_	
15-52	2565-2567	al	_	_	
15-53	2567-2568	.	_	_	
15-54	2568-2569	,	_	_	
15-55	2570-2577	British	_	_	
15-56	2578-2585	Journal	_	_	
15-57	2586-2588	of	_	_	
15-58	2589-2601	Experimental	_	_	
15-59	2602-2611	Pathology	_	_	
15-60	2612-2616	1945	_	_	
15-61	2616-2617	,	_	_	
15-62	2618-2620	26	_	_	
15-63	2620-2621	,	_	_	
15-64	2622-2625	255	_	_	
15-65	2625-2626	-	_	_	
15-66	2626-2629	266	_	_	
15-67	2629-2630	;	_	_	
15-68	2631-2635	Reis	_	_	
15-69	2636-2638	et	_	_	
15-70	2639-2641	al	_	_	
15-71	2641-2642	.	_	_	
15-72	2642-2643	,	_	_	
15-73	2644-2655	Transfusion	_	_	
15-74	2656-2660	1993	_	_	
15-75	2660-2661	,	_	_	
15-76	2662-2664	33	_	_	
15-77	2664-2665	,	_	_	
15-78	2666-2669	639	_	_	
15-79	2669-2670	-	_	_	
15-80	2670-2673	643	_	_	
15-81	2673-2674	)	_	_	
15-82	2674-2675	.	_	_	

#Text=In this assay the aggregation of multiple beads or cells into clumps mediated by some biomolecular recognition event is usually detected as a change in the optical properties of a solution containing the suspended beads/nanoparticles.
16-1	2676-2678	In	_	_	
16-2	2679-2683	this	_	_	
16-3	2684-2689	assay	_	_	
16-4	2690-2693	the	_	_	
16-5	2694-2705	aggregation	_	_	
16-6	2706-2708	of	_	_	
16-7	2709-2717	multiple	_	_	
16-8	2718-2723	beads	_	_	
16-9	2724-2726	or	_	_	
16-10	2727-2732	cells	_	_	
16-11	2733-2737	into	_	_	
16-12	2738-2744	clumps	_	_	
16-13	2745-2753	mediated	_	_	
16-14	2754-2756	by	_	_	
16-15	2757-2761	some	_	_	
16-16	2762-2774	biomolecular	_	_	
16-17	2775-2786	recognition	_	_	
16-18	2787-2792	event	_	_	
16-19	2793-2795	is	_	_	
16-20	2796-2803	usually	_	_	
16-21	2804-2812	detected	_	_	
16-22	2813-2815	as	_	_	
16-23	2816-2817	a	_	_	
16-24	2818-2824	change	_	_	
16-25	2825-2827	in	_	_	
16-26	2828-2831	the	_	_	
16-27	2832-2839	optical	_	_	
16-28	2840-2850	properties	_	_	
16-29	2851-2853	of	_	_	
16-30	2854-2855	a	_	_	
16-31	2856-2864	solution	_	_	
16-32	2865-2875	containing	_	_	
16-33	2876-2879	the	_	_	
16-34	2880-2889	suspended	_	_	
16-35	2890-2895	beads	_	_	
16-36	2895-2896	/	_	_	
16-37	2896-2909	nanoparticles	_	_	
16-38	2909-2910	.	_	_	

#Text=In this type of system the aggregation is very dependent on the ratio of microparticles/nanoparticles to molecule of interest (FIG. 2) and so will only lead to a positive detection if the concentration is within an optimum range.
17-1	2911-2913	In	_	_	
17-2	2914-2918	this	_	_	
17-3	2919-2923	type	_	_	
17-4	2924-2926	of	_	_	
17-5	2927-2933	system	_	_	
17-6	2934-2937	the	_	_	
17-7	2938-2949	aggregation	_	_	
17-8	2950-2952	is	_	_	
17-9	2953-2957	very	_	_	
17-10	2958-2967	dependent	_	_	
17-11	2968-2970	on	_	_	
17-12	2971-2974	the	_	_	
17-13	2975-2980	ratio	_	_	
17-14	2981-2983	of	_	_	
17-15	2984-2998	microparticles	_	_	
17-16	2998-2999	/	_	_	
17-17	2999-3012	nanoparticles	_	_	
17-18	3013-3015	to	_	_	
17-19	3016-3024	molecule	_	_	
17-20	3025-3027	of	_	_	
17-21	3028-3036	interest	_	_	
17-22	3037-3038	(	_	_	
17-23	3038-3041	FIG	_	_	
17-24	3041-3042	.	_	_	
17-25	3043-3044	2	_	_	
17-26	3044-3045	)	_	_	
17-27	3046-3049	and	_	_	
17-28	3050-3052	so	_	_	
17-29	3053-3057	will	_	_	
17-30	3058-3062	only	_	_	
17-31	3063-3067	lead	_	_	
17-32	3068-3070	to	_	_	
17-33	3071-3072	a	_	_	
17-34	3073-3081	positive	_	_	
17-35	3082-3091	detection	_	_	
17-36	3092-3094	if	_	_	
17-37	3095-3098	the	_	_	
17-38	3099-3112	concentration	_	_	
17-39	3113-3115	is	_	_	
17-40	3116-3122	within	_	_	
17-41	3123-3125	an	_	_	
17-42	3126-3133	optimum	_	_	
17-43	3134-3139	range	_	_	
17-44	3139-3140	.	_	_	

#Text=Macroscale methods can be utilized to increase this range, but require centrifugation and resuspension of aggregate (FIG. 3).
18-1	3141-3151	Macroscale	_	_	
18-2	3152-3159	methods	_	_	
18-3	3160-3163	can	_	_	
18-4	3164-3166	be	_	_	
18-5	3167-3175	utilized	_	_	
18-6	3176-3178	to	_	_	
18-7	3179-3187	increase	_	_	
18-8	3188-3192	this	_	_	
18-9	3193-3198	range	_	_	
18-10	3198-3199	,	_	_	
18-11	3200-3203	but	_	_	
18-12	3204-3211	require	_	_	
18-13	3212-3226	centrifugation	_	_	
18-14	3227-3230	and	_	_	
18-15	3231-3243	resuspension	_	_	
18-16	3244-3246	of	_	_	
18-17	3247-3256	aggregate	_	_	
18-18	3257-3258	(	_	_	
18-19	3258-3261	FIG	_	_	
18-20	3261-3262	.	_	_	
18-21	3263-3264	3	_	_	
18-22	3264-3265	)	_	_	
18-23	3265-3266	.	_	_	

#Text=These manual operations are not easily performed in a portable system, and are expensive and time consuming.
#Text=[0032] Flow cytometry (FC) and laser scanning cytometry (LSC) are some of the most widely used techniques for single cell analysis.
19-1	3267-3272	These	_	_	
19-2	3273-3279	manual	_	_	
19-3	3280-3290	operations	_	_	
19-4	3291-3294	are	_	_	
19-5	3295-3298	not	_	_	
19-6	3299-3305	easily	_	_	
19-7	3306-3315	performed	_	_	
19-8	3316-3318	in	_	_	
19-9	3319-3320	a	_	_	
19-10	3321-3329	portable	_	_	
19-11	3330-3336	system	_	_	
19-12	3336-3337	,	_	_	
19-13	3338-3341	and	_	_	
19-14	3342-3345	are	_	_	
19-15	3346-3355	expensive	_	_	
19-16	3356-3359	and	_	_	
19-17	3360-3364	time	_	_	
19-18	3365-3374	consuming	_	_	
19-19	3374-3375	.	_	_	
19-20	3376-3377	[	_	_	
19-21	3377-3381	0032	_	_	
19-22	3381-3382	]	_	_	
19-23	3383-3387	Flow	_	_	
19-24	3388-3397	cytometry	_	_	
19-25	3398-3399	(	_	_	
19-26	3399-3401	FC	_	_	
19-27	3401-3402	)	_	_	
19-28	3403-3406	and	_	_	
19-29	3407-3412	laser	_	_	
19-30	3413-3421	scanning	_	_	
19-31	3422-3431	cytometry	_	_	
19-32	3432-3433	(	_	_	
19-33	3433-3436	LSC	_	_	
19-34	3436-3437	)	_	_	
19-35	3438-3441	are	_	_	
19-36	3442-3446	some	_	_	
19-37	3447-3449	of	_	_	
19-38	3450-3453	the	_	_	
19-39	3454-3458	most	_	_	
19-40	3459-3465	widely	_	_	
19-41	3466-3470	used	_	_	
19-42	3471-3481	techniques	_	_	
19-43	3482-3485	for	_	_	
19-44	3486-3492	single	_	_	
19-45	3493-3497	cell	_	_	
19-46	3498-3506	analysis	_	_	
19-47	3506-3507	.	_	_	

#Text=Well characterized distributions of cellular behavior are often observed using flow cytometry.
20-1	3508-3512	Well	_	_	
20-2	3513-3526	characterized	_	_	
20-3	3527-3540	distributions	_	_	
20-4	3541-3543	of	_	_	
20-5	3544-3552	cellular	_	_	
20-6	3553-3561	behavior	_	_	
20-7	3562-3565	are	_	_	
20-8	3566-3571	often	_	_	
20-9	3572-3580	observed	_	_	
20-10	3581-3586	using	_	_	
20-11	3587-3591	flow	_	_	
20-12	3592-3601	cytometry	_	_	
20-13	3601-3602	.	_	_	

#Text=Briefly, this technique involves the hydrodynamic isolation of individual cells that have been previously labeled using fluorescent dyes that reveal information about the quantity of biomolecules of interest within that cell.
21-1	3603-3610	Briefly	_	_	
21-2	3610-3611	,	_	_	
21-3	3612-3616	this	_	_	
21-4	3617-3626	technique	_	_	
21-5	3627-3635	involves	_	_	
21-6	3636-3639	the	_	_	
21-7	3640-3652	hydrodynamic	_	_	
21-8	3653-3662	isolation	_	_	
21-9	3663-3665	of	_	_	
21-10	3666-3676	individual	_	_	
21-11	3677-3682	cells	_	_	
21-12	3683-3687	that	_	_	
21-13	3688-3692	have	_	_	
21-14	3693-3697	been	_	_	
21-15	3698-3708	previously	_	_	
21-16	3709-3716	labeled	_	_	
21-17	3717-3722	using	_	_	
21-18	3723-3734	fluorescent	_	_	
21-19	3735-3739	dyes	_	_	
21-20	3740-3744	that	_	_	
21-21	3745-3751	reveal	_	_	
21-22	3752-3763	information	_	_	
21-23	3764-3769	about	_	_	
21-24	3770-3773	the	_	_	
21-25	3774-3782	quantity	_	_	
21-26	3783-3785	of	_	_	
21-27	3786-3798	biomolecules	_	_	
21-28	3799-3801	of	_	_	
21-29	3802-3810	interest	_	_	
21-30	3811-3817	within	_	_	
21-31	3818-3822	that	_	_	
21-32	3823-3827	cell	_	_	
21-33	3827-3828	.	_	_	

#Text=A light source, filtering mechanism, and detector are present to observe these signals of individual cells.
22-1	3829-3830	A	_	_	
22-2	3831-3836	light	_	_	
22-3	3837-3843	source	_	_	
22-4	3843-3844	,	_	_	
22-5	3845-3854	filtering	_	_	
22-6	3855-3864	mechanism	_	_	
22-7	3864-3865	,	_	_	
22-8	3866-3869	and	_	_	
22-9	3870-3878	detector	_	_	
22-10	3879-3882	are	_	_	
22-11	3883-3890	present	_	_	
22-12	3891-3893	to	_	_	
22-13	3894-3901	observe	_	_	
22-14	3902-3907	these	_	_	
22-15	3908-3915	signals	_	_	
22-16	3916-3918	of	_	_	
22-17	3919-3929	individual	_	_	
22-18	3930-3935	cells	_	_	
22-19	3935-3936	.	_	_	

#Text=The technique is a very high throughput serial process, where in most cases cells are discarded after analysis.
23-1	3937-3940	The	_	_	
23-2	3941-3950	technique	_	_	
23-3	3951-3953	is	_	_	
23-4	3954-3955	a	_	_	
23-5	3956-3960	very	_	_	
23-6	3961-3965	high	_	_	
23-7	3966-3976	throughput	_	_	
23-8	3977-3983	serial	_	_	
23-9	3984-3991	process	_	_	
23-10	3991-3992	,	_	_	
23-11	3993-3998	where	_	_	
23-12	3999-4001	in	_	_	
23-13	4002-4006	most	_	_	
23-14	4007-4012	cases	_	_	
23-15	4013-4018	cells	_	_	
23-16	4019-4022	are	_	_	
23-17	4023-4032	discarded	_	_	
23-18	4033-4038	after	_	_	
23-19	4039-4047	analysis	_	_	
23-20	4047-4048	.	_	_	
